preclinical and clinical evaluation of the effect of siddha classical drug KANAI KIRUTHAM(oral administration)in the management of WHEEZING ASSOCIATED LOWER RESPIRATORY TRACT INFECTION

preclinical and clinical evaluation of the effect on oral administration of KANAI KIRUTHAM in the management of SINGI MANTHA KANAM

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/02/039924

Enrollment

Registered

2022-02-02

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: KANAI KIRUTHAM (oral administration): should be administrated orally twice a day after food for a period of 14 days dose -5gm to 8gm Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1.Cough (productive or dry ) 2.Difficulty in breathing (Respiratory cause only) 3.Wheezing 4.Fever 5. Allergic asthma

Exclusion criteria

Exclusion criteria: 1.Children above 13years 2.Children below 3 years 3.Difficulty in breathing other than the respiratory cause 4.Congestive cardiac failure 5.ARDS 6.Silent chest 7.Emergency case

Design outcomes

Primary

Measure	Time frame
Reduction in clinical symptoms like cough, difficulty in breathing, wheezing, low grade fever, mild head ache.Timepoint: Reduction in clinical symptoms like cough, difficulty in breathing, wheezing, low grade fever, mild head ache.	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr D K SOUNDARARAJAN MD s

Government Siddha Medical College and Hospital, Palayamkottai.

dr.dks2012@gmail.com9442048801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026